Previous Close | 103.88 |
Open | 103.79 |
Bid | 103.82 x 1300 |
Ask | 103.89 x 800 |
Day's Range | 102.65 - 104.00 |
52 Week Range | 99.14 - 119.65 |
Volume | |
Avg. Volume | 7,310,698 |
Market Cap | 262.905B |
Beta (5Y Monthly) | 0.35 |
PE Ratio (TTM) | 57.96 |
EPS (TTM) | 1.79 |
Earnings Date | Feb 01, 2024 |
Forward Dividend & Yield | 3.08 (2.97%) |
Ex-Dividend Date | Dec 14, 2023 |
1y Target Est | 124.90 |
Subscribe to Yahoo Finance Plus to view Fair Value for MRK
In this article, we will take a look at the 12 healthcare stocks billionaires like the most. To skip our analysis of the recent market trends and activity, you can go directly to see the 5 Healthcare Stocks Billionaires Like the Most. The healthcare sector includes companies ranging from pharmaceuticals, medical equipment and device manufacturers, […]
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...
After a late-stage study fails to show any improvement in its primary endpoints, Merck (MRK) decides to stop evaluating the Keytruda-Lynparza combination in metastatic squamous NSCLC.